Evidence & access
How to choose a GLP-1 provider: a 5-minute checklist
A plain-English, five-minute checklist for vetting a GLP-1 telehealth provider — price stability, accreditation, supply, and the fine print that matters.
Updated · Editorial standards
In this brief
There are now hundreds of telehealth providers selling GLP-1 medication, and from the outside most of them look the same: a clean website, a low headline price, a promise to ship this week. The differences that actually matter are usually a click or two below the fold. This is the checklist we run before we score any provider on the Dose Brief ranking — you can run it yourself in about five minutes.
1. Is the price the price?
Start with the number, but don't stop there. The single most common trap in this market is the teaser rate: a low first-month price that steps up sharply once you're on the medication and least likely to switch. Before you sign up, find the ongoing monthly cost, not just the intro cost — and check whether there's a separate membership or consultation fee stacked on top.
Those fees can be charged even when nothing is prescribed: Synergy Rx bills an $80 telehealth visit whether or not you receive medication, and that figure appears in none of its advertised prices — so a reader who is declined still pays. A provider that publishes one flat, all-in price you can plan around is worth more than a provider that leads with a cheaper number that doesn't hold.
And check that there is a price to find at all: Oak advertises nine different "starting" figures at once and attaches a term to none of them, with its two cheapest appearing only beside a discount its own affiliate page describes as "$200 off 3-months" — none of the nine is the rate you would actually be billed — that is $200/mo for semaglutide and $250 for tirzepatide, published on the first screen of its order form. Three of its marketing pages also promise "Membership Fees: None" and "No subscriptions" while its own Terms say patients are charged a membership fee for a provider consult and that most prescriptions renew recurringly, which is the exact fine print this checklist exists to send you looking for.
We dig into that dynamic in why GLP-1 prices move. If tirzepatide is the molecule you're after, our cheapest-tirzepatide tracker shows who's actually cheapest this cycle and flags which providers reach your state.
2. Is it a legitimate, accredited pharmacy?
A pharmacy license or outsourcing-facility registration alone does not establish that a compounded GLP-1 offer meets legal requirements. FDA’s 503A framework includes patient-specific prescription and essential-copy limits; 503B facilities face separate bulk-ingredient and copy restrictions3. Check the actual dispensing pharmacy’s license and identity. A LegitScript badge is an additional verification step, not FDA approval of the drug or proof that your prescription meets those conditions45.
If a site won't tell you who actually compounds and ships your medication, treat that as a yellow flag. Our companion guide, is compounded semaglutide legit?, walks through exactly what to check, and our compounded semaglutide supply page shows who's actually selling it and at what price right now.
Most providers fail this one: of seven we read in August 2026, only two named a pharmacy at all, and Trellis Vitality was one of them — VialsRX, in Houston, disclosed in the site's own machine-readable file rather than buried. Note also that a certification badge is only as good as what it links to: Rehydra+ claims certification with a self-hosted image linking to a keyword search and publishes no seal identifier, which leaves the claim unverifiable rather than disproved.
3. Brand-name or compounded — and do you have a choice?
Some providers only sell compounded semaglutide or tirzepatide; others can also route you to FDA-approved brand-name products like Wegovy or Zepbound, sometimes with insurance navigation12. FDA-approved drugs have undergone the agency’s review; compounded preparations have not. A compounded prescription may be appropriate for an individual medical need when the applicable conditions are met. Discuss that decision with your prescriber, then confirm the provider can supply the exact prescribed product34. The trade-offs are laid out in compounded vs brand-name GLP-1, explained.
4. Will it ship to your state, reliably?
Telehealth prescribing is regulated state by state, and not every provider serves every state. Confirm your state is on the list before you get attached to a price. While you're there, look for signals of a stable supply chain — a provider that names its sourcing and hasn't had public supply interruptions is a safer bet than one that's silent about it. Supply is a live issue in this category; see GLP-1 shortages and supply for the current picture.
5. Read the medical fine print
GLP-1 medications carry a boxed warning about thyroid C-cell tumors seen in rodent studies, and they're contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN 212 — see what that warning actually means in humans for the real-world evidence. A responsible provider also asks about GI history (relevant to the rare but real risk covered in GLP-1 lawsuits and gastroparesis: what the evidence shows), any personal or family history relevant to the NAION eye-safety signal, and any upcoming surgery or procedure — see GLP-1s before surgery for why that last one matters and should be flagged proactively, not left for you to bring up. A responsible provider screens for this and puts a real clinician between you and the prescription. If the intake feels like a formality — no meaningful health questions, no clinician contact — that's a reason to slow down and ask more.
6. Can you leave?
Finally, check the exit. How hard is it to cancel? Is there a lock-in, a coaching subscription you can't unbundle, or an auto-renew that's easy to miss? The best providers make leaving as easy as joining, because they're confident you'll stay for the right reasons.
Put it together
Run those six checks and most providers sort themselves quickly. If you'd rather start from a shortlist, our provider briefs score every provider we track on price stability, supply reliability, transparency, access, clinical oversight, and track record — the six factors behind the Brief Score. You can also put any two side by side on our compare pages. None of this is medical advice; it's a way to ask sharper questions before you talk to a clinician.
Before paying, verify the exact dispensing pharmacy and read our cancellation and refunds guide. A provider name and a low starting price do not answer those questions.
Before paying, clarify lab testing charges and the service’s privacy and data-sharing practices. If you already have a prescriber, our provider-switching checklist separates the clinical handoff from subscription cancellation.
Frequently asked questions
What's the single most important thing to check?
Whether the headline price is the ongoing price. Teaser rates that step up after the first month are the most common cost surprise in this market, so always find the standing monthly cost before you sign up.
How do I know a compounded GLP-1 provider is legitimate?
Verify the actual pharmacy, its license and the prescribing clinician. Ask why a compounded product is appropriate for you and how the applicable compounding conditions are met. A certification badge or pharmacy registration does not establish FDA approval or lawful fulfillment of your particular prescription.
Is compounded or brand-name better?
FDA-approved products have been reviewed for safety, effectiveness and quality. Compounded drugs are not FDA-approved and may be appropriate for a specific medical need when applicable requirements are met. Discuss the exact medication and its alternatives with your prescriber; do not choose on price alone.
References
- U.S. Food and Drug Administration (2024). Wegovy (semaglutide) injection — Drugs@FDA prescribing information. FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256
- U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) injection — Drugs@FDA prescribing information. FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806
- U.S. Food and Drug Administration (2026). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
- U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Food and Drug Administration (2026). Is It Really FDA Approved?. FDA. https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Mounjaro vs Zepbound vs compounded tirzepatide: what's actually different
Mounjaro, Zepbound, and compounded tirzepatide share a molecule but differ in approval, indication, dosing, and price — here's the plain-English breakdown.
ReadCompounded vs brand-name GLP-1, explained
What separates compounded semaglutide and tirzepatide from brand-name Wegovy and Zepbound — on price, regulation, supply, and what the labels actually cover.
ReadGLP-1 telehealth privacy: what to check before sharing data
Separate the medical practice from the app, review data-sharing choices, and use this privacy checklist before completing an intake.
ReadIs GLP-1 telehealth legal in my state?
The three questions that actually determine whether a GLP-1 telehealth provider can legally treat you — prescriber licensure, pharmacy licensure, and coverage.
ReadSwitching GLP-1 providers: records, refills and the handoff
A practical handoff checklist for changing GLP-1 telehealth services without confusing records, prescriptions and subscription cancellation.
ReadWhy GLP-1 prices move: teaser rates, step-ups, and supply
The forces behind GLP-1 pricing — teaser rates, month-two step-ups, stacked fees, and supply — and how to read a monthly price so it won't surprise you.
Read